The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry

dc.contributor.author	MUSLUMANOGLU, O. A. H.
dc.contributor.author	Bakkaloglu, Doğu
dc.contributor.author	CIFTCI, H. Sentuk
dc.contributor.author	CINAR, C. Kekik
dc.contributor.author	AR, M. C.
dc.contributor.author	TUZUNER, N.
dc.contributor.author	EKIZOGLU, S.
dc.date.accessioned	2021-03-03T16:38:21Z
dc.date.available	2021-03-03T16:38:21Z
dc.identifier.citation	Bakkaloglu D., CIFTCI H. S. , MUSLUMANOGLU O. A. H. , EKIZOGLU S., CINAR C. K. , AR M. C. , TUZUNER N., "The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry", VIRCHOWS ARCHIV, cilt.469, 2016
dc.identifier.issn	0945-6317
dc.identifier.other	vv_1032021
dc.identifier.other	av_45485a26-a387-47c9-97b5-1fb76e52b887
dc.identifier.uri	http://hdl.handle.net/20.500.12627/50246
dc.language.iso	eng
dc.subject	Temel Tıp Bilimleri
dc.subject	Biyokimya
dc.subject	Cerrahi Tıp Bilimleri
dc.subject	Patoloji
dc.subject	Yaşam Bilimleri
dc.subject	Temel Bilimler
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Yaşam Bilimleri (LIFE)
dc.subject	Biyoloji ve Biyokimya
dc.subject	PATOLOJİ
dc.title	The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry
dc.type	Makale
dc.relation.journal	VIRCHOWS ARCHIV
dc.contributor.department	, ,
dc.identifier.volume	469
dc.contributor.firstauthorID	84008

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.